ProteoGenix Clinical Laboratory:: Advancing Maternal/Fetal/Neonatal Diagnosis

Preterm labor is frequently caused by intraamniotic infections (IAI)

Intraamniotic infection is a critical complication of pregnancy significantly increasing the risk of morbidity
There is increasing awareness of the prevalence of IAI in 15%-18% of preterm labor cases and the importance of early detection
Amniotic fluid culture alone underestimates the true prevalence of IAI by as much as 30-50% of cases
Detection of IAI may be difficult as 80% to 90% of all cases are asymptomatic
In the absence of clinical symptoms, and given the limitations of current IAI diagnostic tools, routinely assessing Preterm labor patients for IAI can be difficult and cases can remain undiagnosed and untreated

Our mission is to develop innovative, highly effective diagnostic tests for prompt and
more accurate identification and treatment of significant complications of pregnancy

our focus

A complete menu of diagnostic tests for intraamniotic
infections enabling you to make better decisions, sooner

Expanding amniotic fluid test results

Our competency is applying molecular microbiology techniques specifically in amniotic fluid (AF) to aid clinical diagnosis of intraamniotic infection (IAI)
The first commercially available 16S rDNA polymerase chain reaction (PCR) test for detection of bacterial/Mycoplasma and Ureaplasma species DNA in amniotic fluid

Unlocking the proteome for clinical use

ProteoGenix is the first company to map the "proteome of pregnancy", identifying more than 800 unique proteins in the key biological fluids of pregnancy

Utilizing less invasive diagnostic tools

Proteomic biomarkers and molecular microbiology techniques differentiate disease from nondisease across many critical conditions associated with pregnancy, creating potential for innovative, highly, less invasive diagnostic tools

laboratory overview

CLIA-certified reference laboratory
Comprehensive menu of state-of-the-art amniotic fluid (AF) testing for intraamniotic infection ( IAI)
Based on recent scientific research and utilizing leading technology, ProteoGenix IAI tests, both current and upcoming, provide clinicians with new tools to allow greater confidence in diagnosing and managing IAI in preterm labor ( PTL) patients.
On the horizon: a new generation of noninvasive tests